Vera therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Brisbane, calif., april 09, 2025 (globe newswire) -- vera therapeutics, inc. (nasdaq: vera) today announced that on april 3, 2025, the compensation committee granted inducement awards consisting of non-qualified stock options to purchase 211,250 shares of class a common stock and restricted stock units (rsus) for 105,125 shares of class a common stock to sixteen (16) new employees under the inducement plan. the compensation committee approved the awards as an inducement material to the new employees' employment in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking